Testing effectiveness (Phase 2)UnknownNCT02803840What this trial is testingLow-dose Radiotherapy for Diffuse Large B-cell LymphomaWho this might be right forLymphoma Centro di Riferimento Oncologico - Aviano 25
Early research (Phase 1)Looking for participantsNCT06708897What this trial is testingLonitoclax (ZE50-0134) in Relapsed or Refractory B-cell MalignanciesWho this might be right forCLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)+2 more Lomond Therapeutics Holdings, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00040846What this trial is testingAlemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT02061761What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesWho this might be right forHematologic Neoplasms Bristol-Myers Squibb 106
Very early researchLooking for participantsNCT07548697What this trial is testingA Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin LymphomaWho this might be right forB-cell Non Hodgkin Lymphoma (NHL)DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT03610724What this trial is testingPhase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma PatientsWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 34
Early research (Phase 1)Looking for participantsNCT05741359What this trial is testingThe Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin LymphomaWho this might be right forNon-hodgkin Lymphoma,B Cell Bioray Laboratories 18
Post-approval studies (Phase 4)Looking for participantsNCT06876662What this trial is testing(LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaWho this might be right forChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma Eli Lilly and Company 279
Early research (Phase 1)Active Not RecruitingNCT04594642What this trial is testingAZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more AstraZeneca 226
Testing effectiveness (Phase 2)UnknownNCT03598179What this trial is testingXLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy SubjectsWho this might be right forLymphoma, B-CellLeukemia, B-cell The First Affiliated Hospital with Nanjing Medical University 10
Early research (Phase 1)Looking for participantsNCT07239323What this trial is testingIn VIVO CAR-T Therapy for Relapsed/Refractory Hematological MalignanciesWho this might be right forB-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma Chongqing Precision Biotech Co., Ltd 24
Not applicableLooking for participantsNCT03280394What this trial is testingLiquid Biopsy in Mature B-cell TumorsWho this might be right forMature B-Cell Neoplasm Oncology Institute of Southern Switzerland 444
Not applicableLooking for participantsNCT06710418What this trial is testingEvaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/LeukemiaWho this might be right forAcute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more University of Washington 50
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Not applicableStudy completedNCT07103486What this trial is testingEvaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Novartis Pharmaceuticals 264
Early research (Phase 1)Ended earlyNCT06028373What this trial is testingATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin LymphomasWho this might be right forAdvanced Solid TumorsB-cell Non-Hodgkin Lymphomas Antengene Biologics Limited 38
Early research (Phase 1)UnknownNCT05453669What this trial is testingClinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHLWho this might be right forB-cell Non-Hodgkin's Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)WithdrawnNCT04052061What this trial is testingQUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaLarge-cell LymphomaLymphoma, B-Cell+1 more ImmunityBio, Inc.
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69